A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07336472 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07336472
- Sponsor
- Fortvita Biologics (USA)Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-01
- Primary completion
- 2027-12-31
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.